The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Clinical significance of serum tumor markers for gastric cancer: a systematic review of literature by the Task Force of the Japanese Gastric Cancer Association
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2011) · Hepatogastroenterology · doi:10.5754/hge11125 · Cited by 2,450
(2011) · Hepatogastroenterology · doi:10.5754/hge11753 · Cited by 2,435
Marrelli, D., Pinto, E., Stefano, A. D., Farnetani, M., Garosi, L., & Roviello, F. (2001) · The American Journal of Surgery · doi:10.1016/s0002-9610(00)00549-3 · Cited by 144
Ychou, M., Duffour, J., Kramar, A., Gourgou, S., & Grenier, J. (2000) · Disease Markers · doi:10.1155/2000/595492 · Cited by 124
Correlation between serum CA724 and gastric cancer: multiple analyses based on Chinese population
Chen, X., Zhang, W., Yang, K., Wang, L., Liu, J., Wang, L., Hu, J.-K., Zhang, B., Chen, Z., Chen, J., et al. (2012) · Molecular Biology Reports · doi:10.1007/s11033-012-1774-x · Cited by 121
Serum interleukin-6 and -10 levels in patients with gastric cancer
Ikeguchi, M., Hatada, T., Yamamoto, M., Miyake, T., Matsunaga, T., Fukumoto, Y., Yamada, Y., Fukuda, K., Saito, H., & Tatebe, S. (2009) · Gastric Cancer · doi:10.1007/s10120-009-0509-8 · Cited by 116
Prognostic Value of Carcinoembryonic Antigen, CA 19-9 and CA 72-4 in Gastric Carcinoma
Gaspar, M. J., Arribas, I., Coca, M., et al. (2001) · Tumor Biology · doi:10.1159/000050633 · Cited by 111
Second-line chemotherapy for patients with advanced gastric cancer: who may benefit?
Catalano, V., Graziano, F., Santini, D., D'Emidio, S., Baldelli, A. M., Rossi, D., Vincenzi, B., Giordani, P., Alessandroni, P., Testa, E., et al. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604732 · Cited by 101
Duraker, N., & Çeli̇k, A. N. (2001) · Journal of Surgical Oncology · doi:10.1002/jso.1044 · Cited by 82
Lai, I., Lee, W.-J., Huang, M., & Lin, H.-H. (2003) · PubMed · Cited by 81
Łukaszewicz‐Zając, M., Mroczko, B., Gryko, M., Kędra, B., & Szmitkowski, M. (2010) · Clinical and Experimental Medicine · doi:10.1007/s10238-010-0114-5 · Cited by 69
The use of tumor markers as predictors of prognosis in gastric cancer.
Mihmanlı, M., Dilege, E., Demir, U., Coskun, H., Eroglu, T., & Uysalol, M. (2004) · PubMed · Cited by 69
Wobbes, T., Thomas, C. M. G., Segers, M. F., & Nagengast, F. M. (1992) · Cancer · Cited by 57
Kim, H. J., Lee, K., Kim, Y. J., Oh, D., Kim, J. H., Im, S., & Lee, J. S. (2008) · Acta Oncologica · doi:10.1080/02841860802446761 · Cited by 35
Investigation of serum tumor markers in the diagnosis of gastric cancer.
Fan, B., & Xiong, B. (2011) · PubMed · Cited by 32
Cited by
Biomarkers of gastric cancer: Current topics and future perspective
Matsuoka, T., & Yashiro, M. (2018) · World Journal of Gastroenterology · doi:10.3748/wjg.v24.i26.2818 · Cited by 476
Recent advances in gastric cancer early diagnosis
Necula, L., Matei, L., Dragu, D., Neagu, A. I., Mambet, C., Nedeianu, S., Bleotu, C., Diaconu, C. C., & Chivu-Economescu, M. (2019) · World Journal of Gastroenterology · doi:10.3748/wjg.v25.i17.2029 · Cited by 435
Using circular RNA hsa_circ_0000190 as a new biomarker in the diagnosis of gastric cancer
Chen, S., Li, T., Zhao, Q., Xiao, B., & Guo, J. (2017) · Clinica Chimica Acta · doi:10.1016/j.cca.2017.01.025 · Cited by 378
Yoshida, K., Yamaguchi, K., Okumura, N., Tanahashi, T., & Kodera, Y. (2016) · Gastric Cancer · doi:10.1007/s10120-015-0575-z · Cited by 350
Yuan, L., Xu, Z.-Y., Ruan, S.-M., Mo, S., Qin, J.-J., & Cheng, X.-D. (2020) · Molecular Cancer · doi:10.1186/s12943-020-01219-0 · Cited by 329
Metadata
- Authors
- Shimada, H., Noie, T., Ohashi, M., Oba, K., & Takahashi, Y.
- Venue
- Gastric Cancer
- Published
- 2013-04-10
- Volume
- 17
- Issue
- 1
- Pages
- 26-33
- ISSN
- 1436-3291 (ISSN-L)
- 1436-3305
- OpenAlex
- W2053354145
- Cited by
- 538
- References
- 15
- FWCI
- 3.22
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.